Life Sciences Products & Reviews

Professional services for site-specific or random labeling of proteins with a variety of tags, including fluorescent dyes, biotin, enzymes, and isotopes, for detection and tracking.

A specialized selection of high-purity, carrier-free cytokines and growth factors optimized for the robust and reproducible growth and differentiation of 3D organoid models.

High-quality recombinant TGF-β superfamily proteins, including TGF-βs, BMPs, and GDFs, for studying cell growth, differentiation, embryogenesis, and tissue repair.

A diverse range of recombinant proteins and antigens associated with specific physiological or pathological states, supporting discovery, assay development, and diagnostic validation.

A service to identify the RNA targets of RNA-binding proteins (RBPs) on a genome-wide scale, providing insights into post-transcriptional regulatory networks.

Recombinant Human B-cell lymphoma 2 (BCL-2) protein, a key regulator of apoptosis (programmed cell death) and a well-established oncoprotein in many cancers.

Recombinant Human B-cell Antigen Receptor Complex-associated protein alpha chain (CD79A), a essential component of the B-cell receptor (BCR) and a marker for B-cell lineage.

Specialized services for the challenging production of functional, stabilized membrane proteins, including GPCRs, ion channels, and transporters, for structural and drug discovery.

End-to-end custom services for the cloning, expression, and purification of soluble recombinant proteins in various host systems, from gene synthesis to purified protein delivery.

Label-free, real-time analysis of biomolecular interactions to determine binding kinetics (kon, koff), affinity (KD), and specificity with high precision and sensitivity.

Monoclonal and polyclonal antibodies with validated performance for the precise detection of disease biomarkers in a wide range of clinical and research immunoassays.

Custom fermentation and purification services to produce gram to kilogram quantities of recombinant proteins for preclinical, clinical, and commercial applications.

A complete set of recombinant interleukins, key signaling molecules of the immune system, for research in immunology, inflammation, cancer, and therapeutic development.

A specialized protein interaction screening service designed to identify interacting partners for membrane proteins, which are typically difficult to study with conventional Y2H.

A powerful technology platform for screening large libraries of antibodies, peptides, or protein domains displayed on phage to identify high-affinity binders against any target.

A diverse collection of proteins engineered for therapeutic use, including cytokines, growth factors, enzymes, and monoclonal antibodies, supporting the development of novel biologic drugs.

A focused set of recombinant immune regulatory proteins, such as PD-1, PD-L1, and CTLA-4, essential for research and drug discovery in cancer immunotherapy and autoimmunity.

A recombinant B-lymphocyte surface antigen, CD19, which is a pivotal target for immunotherapy in B-cell malignancies, including CAR-T cell and antibody-based therapies.

A wide array of recombinant human and animal cytokines, chemokines, and interferons for studying immune responses, inflammation, hematopoiesis, and cell communication.

Recombinant proteins specifically relevant as E3 ligases or target proteins for Proteolysis Targeting Chimeras (PROTACs), enabling the development of this novel targeted protein degradation technology.

A broad selection of recombinant growth factors, such as FGFs, EGF, and VEGF, essential for promoting cell proliferation, survival, and specialization in research and bioprocessing.

Ready-to-use kits providing optimized reagents and protocols for rapid, reliable, and reproducible detection and quantification of specific biological targets or activities.

A portfolio of recombinant immunoglobulins and cell surface proteins serving as critical targets for the development and functional validation of Chimeric Antigen Receptor T-cell (CAR-T) therapies.

A suite of analytical services, including SPR, BLI, and ITC, to quantitatively characterize the binding kinetics, affinity, and thermodynamics of biomolecular interactions.

Recombinant Human Leukocyte Antigen G (HLA-G), a non-classical MHC class I molecule involved in immune tolerance at the maternal-fetal interface and in immune evasion by tumors.